Ratings by H.C. Wainwright (Ed White)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/20/2026 | 60 Degrees Pharmaceuticals Inc | SXTP | Downgrade | Neutral (Buy) |
1.41 (1.45) |
2.84% | Details | |
| 3/31/2025 | Inhibikase Therapeutics Inc | IKT | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/12/2025 | Inhibikase Therapeutics Inc | IKT | Downgrade | Neutral (Buy) |
2.34 (1.67) |
-28.63% | Details | |
| 12/24/2024 | 60 Degrees Pharmaceuticals Inc | SXTP | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/12/2024 | 60 Degrees Pharmaceuticals Inc | SXTP | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/14/2024 | Inhibikase Therapeutics Inc | IKT | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2024 | Inhibikase Therapeutics Inc | IKT | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2024 | Tracon Pharmaceuticals | TCON | Downgrade | Neutral (Buy) |
1.43 (1.43) |
0% | Details | |
| 5/21/2024 | Inhibikase Therapeutics Inc | IKT | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2024 | Tracon Pharmaceuticals | TCON | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | Tracon Pharmaceuticals | TCON | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2023 | 60 Degrees Pharmaceuticals Inc | SXTP | New Coverage | Neutral (N/A) |
0.82 (1.17) |
42.68% | Details | |
| 7/3/2023 | Inhibikase Therapeutics Inc | IKT | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2023 | Inhibikase Therapeutics Inc | IKT | New Coverage | Buy (N/A) |
0.58 (1.67) |
187.93% | Details | |
| 2/3/2023 | Vyant Bio Inc. | VYNT | Downgrade | Neutral (Buy) |
1.03 (0.26) |
-74.76% | Details | |
| 6/10/2022 | Imara Inc. | IMRA | New Coverage | Neutral (N/A) |
1.22 (17.54) |
1337.7% | Details | |
| 6/2/2022 | Aeglea Biotherapeutics | AGLE | Downgrade | Neutral (Buy) |
1.50 (12.01) |
700.67% | Details | |
| 3/8/2022 | Vyant Bio Inc. | VYNT | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Mersana | MRSN | Maintain | Buy (N/A) |
|
Details | ||
| 12/28/2021 | Tracon Pharmaceuticals | TCON | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2021 | Vyant Bio Inc. | VYNT | New Coverage | Buy (N/A) |
2.21 (0.26) |
-88.24% | Details | |
| 8/30/2021 | Mersana | MRSN | New Coverage | Buy (N/A) |
13.01 (29.08) |
123.52% | Details | |
| 9/17/2020 | Tracon Pharmaceuticals | TCON | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2020 | Tracon Pharmaceuticals | TCON | Maintain | Buy (N/A) |
|
Details |
